Evidence map›Paper›PMID 36712823›Full record

ArticleMayo Clinic proceedings. Innovations, quality & outcomes2023

Changes in Kidney and Liver Volumes in Patients With Autosomal Dominant Polycystic Kidney Disease Before and After Dialysis Initiation.

Tatsuya Suwabe, Yoshifumi Ubara, Yuki Oba, Hiroki Mizuno, Daisuke Ikuma, Masayuki Yamanouchi, Akinari Sekine, Kiho Tanaka, Eiko Hasegawa, Junichi Hoshino and 1 more

Abstract read
In one paragraph

Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tatsuya SuwabeDepartment of Nephrology, Toranomon Hospital, Tokyo and Kawasaki, Japan.
Yoshifumi UbaraDepartment of Nephrology, Toranomon Hospital, Tokyo and Kawasaki, Japan.
Yuki ObaDepartment of Nephrology, Toranomon Hospital, Tokyo and Kawasaki, Japan.
Hiroki MizunoDepartment of Nephrology, Toranomon Hospital, Tokyo and Kawasaki, Japan.
Daisuke IkumaDepartment of Nephrology, Toranomon Hospital, Tokyo and Kawasaki, Japan.
Masayuki YamanouchiDepartment of Nephrology, Toranomon Hospital, Tokyo and Kawasaki, Japan.
Akinari SekineDepartment of Nephrology, Toranomon Hospital, Tokyo and Kawasaki, Japan.
Kiho TanakaDepartment of Nephrology, Toranomon Hospital, Tokyo and Kawasaki, Japan.
Eiko HasegawaDepartment of Nephrology, Toranomon Hospital, Tokyo and Kawasaki, Japan.
Junichi HoshinoDepartment of Nephrology, Toranomon Hospital, Tokyo and Kawasaki, Japan.
Naoki SawaDepartment of Nephrology, Toranomon Hospital, Tokyo and Kawasaki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To examine the changes in total kidney volume (TKV) and total liver volume (TLV) before and after dialysis initiation in patients with autosomal dominant polycystic kidney disease. Patients and Methods: This was a retrospective, single-center cohort study to investigate the changes in TKV and TLV before and after dialysis initiation, along with influencing factors, using linear mixed models. We enrolled 95 patients with autosomal dominant polycystic kidney disease (85 receiving hemodialysis [HD] and 10 receiving peritoneal dialysis [PD]) who began receiving dialysis at Toranomon Hospital from January 1, 2008, to December 31, 2020. Results: The least squares mean TKV ratio (TKV at each time point/TKV at dialysis initiation) was 63.8% (95% confidence interval [CI], 54.7%-72.9%) at 6 years before dialysis initiation and 95.5% (95% CI, 82.9%-108.2%) at 6 years after dialysis initiation ( Conclusion: The TKV increased until dialysis initiation and generally decreased after dialysis initiation. The TLV continued to increase even after dialysis initiation, however, changes in the TLV significantly decreased after dialysis initiation. The increases in TKV and TLV were greater in patients on PD than in those on HD.

Indexed as

ACDK, acquired cystic disease of the kidneyADPKD, autosomal dominant polycystic kidney diseaseALB, albuminBMI, body mass indexBP, blood pressureCI, confidence intervalCT, computed tomographyeGFR, estimated glomerular filtration rateESKD, end-stage kidney diseaseHD, hemodialysisHR, heart rateMRI, magnetic resonance imagingPD, peritoneal dialysisPKD, polycystic kidney diseasePLD, polycystic liver diseaseTAE, transcatheter arterial embolizationTKV, total kidney volumeTLV, total liver volumeUN, urea nitrogen

Identifiers

PMID36712823
PMCPMC9873948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.